Functional characterization of monocyte-derived dendritic cells generated under serumfree culture conditions

Immunology Letters

Volumn 99, Issue 2, 2005, Pages 209-216

  Lehner, Manfred ^a   Morhart, Patrick ^a   Stilper, Andrea ^a   Holter, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

CD1a; Dendritic cells; IL 12; Serumfree

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELL MATURATION; CULTURE MEDIUM; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

ANTIGENS, CD1; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYTOKINES; DENDRITIC CELLS; HUMANS; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; PHENOTYPE; PROTEIN SUBUNITS; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTORS;

EID: 22044437114     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.02.016     Document Type: Article

References (38)

1. G. Schuler, B. Schuler-Thurner, and R.M. Steinman The use of dendritic cells in cancer immunotherapy Curr Opin Immunol 15 2003 138 147
2. N. Romani, D. Reider, M. Heuer, S. Ebner, E. Kampgen, and B. Eibl Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Methods 196 1996 137 151
3. K. Duperrier, A. Eljaafari, C. Dezutter-Dambuyant, C. Bardin, C. Jacquet, and K. Yoneda Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements J Immunol Methods 238 2000 119 131
4. Y. Suen, S.M. Lee, F. Aono, S. Hou, M. Loudovaris, and G. Ofstein Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC Cytotherapy 3 2001 365 375
5. B. Goxe, N. Latour, M. Chokri, J.P. Abastado, and M. Salcedo Simplified method to generate large quantities of dendritic cells suitable for clinical applications Immunol Invest 29 2000 319 336
6. C. Boccaccio, S. Jacod, A. Kaiser, A. Boyer, J.P. Abastado, and A. Nardin Identification of a clinical-grade maturation factor for dendritic cells J Immunother 25 2002 88 96
7. I.J. de Vries, A.A. Eggert, N.M. Scharenborg, J.L. Vissers, W.J. Lesterhuis, and O.C. Boerman Phenotypical and functional characterization of clinical grade dendritic cells J Immunother 25 2002 429 438
8. C.A. Guyre, J.L. Fisher, M.G. Waugh, P.K. Wallace, C.G. Tretter, and M.S. Ernstoff Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications J Immunol Methods 262 2002 85 94
9. V. Pullarkat, R. Lau, S.M. Lee, J.G. Bender, and J.S. Weber Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells J Immunol Methods 267 2002 173 183
10. + T cell recruitment and proliferation are dependent on stage of dendritic cell maturation Eur J Immunol 33 2003 162 171
11. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells J Exp Med 193 2001 233 238
12. H. Jonuleit, A. Giesecke-Tuettenberg, T. Tuting, B. Thurner-Schuler, T.B. Stuge, and L. Paragnik A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection Int J Cancer 93 2001 243 251
13. I.J. de Vries, W.J. Lesterhuis, N.M. Scharenborg, L.P. Engelen, D.J. Ruiter, and M.J. Gerritsen Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients Clin Cancer Res 9 2003 5091 5100
14. D. McIlroy, and M. Gregoire Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact Cancer Immunol Immunother 52 2003 583 591
15. H. Rouard, J. Marquet, A. Leon, P. Maison, C. Haioun, and C. Copie-Bergman IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells J Immunother 25 2002 324 333
16. K.G. Huttner, S.K. Breuer, P. Paul, O. Majdic, A. Heitger, and T. Felzmann Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells Cancer Immunol Immunother 54 2005 67 77
17. A. Camporeale, A. Boni, G. Iezzi, E. Degl'Innocenti, M. Grioni, and A. Mondino Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes Cancer Res 63 2003 3688 3694
18. Felzmann T, Huttner KG, Breuer SK, Wimmer D, Ressmann G, Wagner D, et al. Semimature IL-12 secreting dendritic cells present exogeneous antigen to trigger cytolytic immune responses. Cancer Immunol Immunother 2005 Jan 13; (Epub ahead of print).
19. M. Lehner, and W. Holter Endotoxin-free purification of monocytes for dendritic cell generation via discontinuous density gradient centrifugation based on diluted Ficoll-Paque Plus(R) Int Arch Allergy Immunol 128 2002 73 76
20. H. Jonuleit, U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, and E. Schmitt Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur J Immunol 27 1997 3135 3142
21. T. Luft, M. Jefford, P. Luetjens, T. Toy, H. Hochrein, and K.A. Masterman Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets Blood 100 2002 1362 1372
22. Y. Dutronc, and S.A. Porcelli The CD1 family and T cell recognition of lipid antigens Tissue Antigens 60 2002 337 353
23. A. Krug, R. Uppaluri, F. Facchetti, B.G. Dorner, K.C. Sheehan, and R.D. Schreiber IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation J Immunol 169 2002 6079 6083
24. R. Forster, A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, and E. Wolf CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs Cell 99 1999 23 33
25. G. Trinchieri Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 3 2003 133 146
26. P. Kalinski, P.L. Vieira, J.H. Schuitemaker, E.C. de Jong, and M.L. Kapsenberg Prostaglandin E(2) is a selective inducer of interleukin-12p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer Blood 97 2001 3466 3469
27. F. Re, and J.L. Strominger Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness J Biol Chem 277 2002 23427 23432
28. M. Cella, M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia Maturation, activation, and protection of dendritic cells induced by double-stranded RNA J Exp Med 189 1999 821 829
29. R.M. Verdijk, T. Mutis, B. Esendam, J. Kamp, C.J. Melief, and A. Brand Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells J Immunol 163 1999 57 61
30. R. Spisek, L. Bretaudeau, I. Barbieux, K. Meflah, and M. Gregoire Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use Cancer Immunol Immunother 50 2001 417 427
31. V. Verhasselt, C. Buelens, F. Willems, D. De Groote, N. Haeffner-Cavaillon, and M. Goldman Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway J Immunol 158 1997 2919 2925
32. C.M. Hilkens, P. Kalinski, M. de Boer, and M.L. Kapsenberg Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype Blood 90 1997 1920 1926
33. C.L. Ahonen, S.J. Gibson, R.M. Smith, L.K. Pederson, J.M. Lindh, and M.A. Tomai Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848 Cell Immunol 197 1999 62 72
34. M. Fogel, J.A. Long, P.J. Thompson, and J.W. Upham Dendritic cell maturation and IL-12 synthesis induced by the synthetic immune-response modifier S-28463 J Leukoc Biol 72 2002 932 938
35. M. Triantafilou, and K. Triantafilou Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster Trends Immunol 23 2002 301 304
36. + blood monocytes in the presence of human serum albumin for use in clinical vaccine trials Br J Haematol 114 2001 681 689
37. R. Josien, H.L. Li, E. Ingulli, S. Sarma, B.R. Wong, and M. Vologodskaia TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo J Exp Med 191 2000 495 502
38. K. Liu, T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R.M. Steinman Immune tolerance after delivery of dying cells to dendritic cells in situ J Exp Med 196 2002 1091 1097